Abstract
This study explored the molecular arrangement of the drug molecule zidovudine (AZT) within an inclusion complex of β-cyclodextrin (βCD). The intrinsic mechanistic profiling of the AZT–βCD inclusion complex was investigated using molecular modeling and structurally designed docking studies via molecular mechanics Force-Field simulations. The energetically and geometrically optimized molecular conformations revealed that the AZT molecule was preferentially oriented toward the primary rim of the βCD cavity with the azido group positioned within the cyclodextrin ring. In the second phase of this study, the mechanism of AZT permeability across the transmucosal membrane after inclusion into βCD was elucidated via interaction between βCD and the transmucosal lipid, glycosylceramide (GLC). Interestingly, βCD formed H-bonds with the lipid head groups of GLC via the secondary rim. A systematic merge of these findings elucidated a novel “tunnel model” designated to the trimolecular complex: AZT-1°ring–βCD-2°ring–GLC. The energetic parameters, grid surface area, molecular volume, surface-to-volume-ratio, Log-P, refractivity, and polarizability were computed for the molecular complexes. Computationally, the Molecular Mechanics Assisted Model Building and Energy Refinements (AMBER) algorithm was used to develop a molecular mechanics energy relationship (MMER). The MMER elucidated the role of destabilized bond stretching, angle modification and torsional strain in ionic stabilization of the geometrical complexes through hydrophobic H-bonding and electrostatic interactions. These results provided a novel bonding and non-bonding correlation for the formation and performance of βCD in terms of its role in the prospective permeation modification of the AZT molecule through the transmucosal membrane with an optimum hydrophilic–lipophilic-permeation balance.
Similar content being viewed by others
References
Gay, C.L., Cohen, M.S.: Antiretrovirals to prevent HIV infection: pre- and post-exposure prophylaxis. Curr. Infect. Dis. Rep. 10, 323–331 (2008)
Pecková, K., Navrátil, T., Yosypchuk, B., Moreira, J.C., Leandro, K.C., Barek, J.: Voltammetric determination of azidothymidine using silver solid amalgam electrodes. Electroanalysis 21, 1750–1757 (2009)
Weinberg, A., Forster-Harwood, J., Davies, J., McFarland, E. J., Pappas, J., Kinzie, K., Barr, E., Paul, S., Salbenblatt, C., Soda, E., Vazquez, A., Levin, M.J.: Clinical study safety and tolerability of antiretrovirals during pregnancy. Infect. Dis. Obstet. Gynecol. (2011). doi:10.1155/2011/867674
Suwanpidokkul, N., Thongnopnua, P., Umprayn, K.: Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS PharmSciTech 5, 82–89 (2004)
Scruggs, E.R., Dirks Naylo, A.J.: Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology 82, 83–88 (2008)
Kim, J.Y., Yoon, Y.S., Park, K.D., Koo, H.: Myopathy due to chronic clevudine therapy. Korean J. Pathol. 43, 575–579 (2009)
Narishetty, S.T., Panchagnula, R.: Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J. Control Release 95, 367–379 (2004)
Parang, K., Wiebe, L.I., Knaus, E.E.: Novel approaches for designing 5′-O-ester prodrugs of 3′-azido-2′3′-dideoxythymidine (AZT). Curr. Med. Chem. 7, 995–1039 (2000)
Brewster, M.E., Loftsson, T., Amselem, S., Friedmand, D., Yogev, A., Anderson, W.R., Helton, D.O., Dinculescu, A., Bodor, N., Pop, E.: Formulation development for a zidovudine chemical delivery system 1. Parenteral dosage forms. Int. J. Pharm. 125, 17–30 (1995)
Amselem, S., Friedman, D., Yogev, A., Anderson, W.R., Helton, D.O., Loftsson, T., Bodor, N., Pop, E., Brewster, M.E.: Formulation development for a zidovudine chemical delivery system 2. Towards oral and non-parenteral dosage forms. Int. J. Pharm. 125, 31–43 (1995)
Thomas, N.S., Panchagnula, R.: Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur. J. Pharm. Sci. 18, 71–79 (2003)
Silion, M., Dascalu, A., Simionescu, B.C., Pinteala, M., Ungurenasu, C.: Synthesis and anti-HIV activity of b-cyclodextrin-C6-sulfate/3-azido-30-deoxythymidine inclusion complex. J. Polym. Sci. A Polym. Chem. 49, 1730–1733 (2011)
Chung, I., Lee, C.K., Ha, C.K., Cho, W.J.: Syntheses of cyclodextrin–30-azido-30-deoxythymidine conjugates and their sulfates with improved anti-HIV activities. J. Polym. Sci. A Polym. Chem. 44, 295–303 (2006)
Consuelo, I.D., Jacques, Y., Pizzolato, G.P., Guy, R.H., Falson, F.: Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Arch. Oral Biol. 50, 981–987 (2005)
Ganem-Quintanar, A., Falson-Rieg, F., Buri, P.: Contribution of lipid components to the permeability barrier of oral mucosa. Eur. J. Pharm. Biopharm. 44, 107–120 (1997)
Glycosyl Group: IUPAC Compendium of Chemical Terminology, vol. 67, p. 1338 (1995)
Bonnet, P., Jaime, C., Morin-Allory, L.: α, β and γ-Cyclodextrin dimers. Molecular modeling studies by molecular mechanics and molecular dynamics simulations. J. Org. Chem. 66, 689–692 (2001)
Warhurst, D.C., Craig, J.C., Adagu, I.S., Meyer, D.J., Lee, S.Y.: The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Malaria J. (2001). doi:10.1186/1475-2875-2-26
Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham, T.E., De-Bolt, S., Ferguson, D., Seibel, G., Kollman, P.: AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Phys. Commun. 91, 1–41 (1995)
Kumar, P., Pillay, V., Choonara, Y.E., Modi, G., Naidoo, D., du Toit, L.C.: In silico theoretical molecular modeling for Alzheimer’s disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int. J. Mol. Sci. 12, 694–724 (2011)
Shaikh, R.P., Kumar, P., Choonara, Y.E., du Toit, L.C., Pillay, V.: Crosslinked electrospun PVA nanofibrous membranes: elucidation of their physicochemical, physicomechanical and molecular disposition. Biofabrication (2012). doi:10.1088/1758-5082/4/2/025002
Yu, B.Y., Chung, J.W., Kwak, S.Y.: Reduced migration from flexible poly(vinyl chloride) of a plasticizer containing β-cyclodextrin derivative. Environ. Sci. Technol. 42, 7522–7527 (2008)
Xiao, Y., Lim, H.M., Chung, T.S., Rajagopalan, R.: Acetylation of beta-cyclodextrin surface-functionalized cellulose dialysis membranes with enhanced chiral separation. Langmuir 23, 12990–12996 (2007)
Másson, M., Sigfusson, S.D., Loftsson, T.: Fish skin as a model membrane to study transmembrane drug delivery with cyclodextrins. J. Incl. Phenom. Macroc. Chem. 44, 177–182 (2002)
Acknowledgments
This work is supported by National Research Foundation (NRF) of South Africa.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, P., Choonara, Y.E., du Toit, L.C. et al. In silico elucidation of the inclusion phenomenon and permeation behavior of a zidovudine–cyclodextrin complex via static lattice atomistic simulation. J Incl Phenom Macrocycl Chem 78, 445–455 (2014). https://doi.org/10.1007/s10847-013-0316-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-013-0316-z